DEA Slaps Seven New Opioids into Ban List for Safety
Published Date: 6/26/2025
Proposed Rule
Summary
The DEA is temporarily putting seven new benzimidazole-opioids into Schedule I, meaning they’re now treated as highly controlled and illegal without special permission. This affects anyone who makes, sells, studies, or even holds these drugs, with strict rules and penalties kicking in right away. The move helps keep dangerous substances off the streets while the DEA finishes its full review.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Seven Benzimidazole-Opioids Placed in Schedule I
The DEA is temporarily placing seven benzimidazole-opioid substances into Schedule I of the Controlled Substances Act. When finalized, the Schedule I regulatory controls and the administrative, civil, and criminal sanctions that apply to Schedule I substances will apply to anyone who manufactures, distributes, reverse distributes, imports, exports, conducts research or instructional activities or chemical analysis, or possesses these seven substances.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in